33 research outputs found

    The Global Deterioration Scale for Down Syndrome Population (GDS-DS): A Rating Scale to Assess the Progression of Alzheimer’s Disease

    Get PDF
    Global deterioration scale; Down syndrome; Alzheimer’s diseaseEscala de deteriorament global; Síndrome de Down; Malaltia d'AlzheimerEscala de deterioro global; Síndrome de Down; Enfermedad de AlzheimerThe aim of this study is to adapt and validate the global deterioration scale (GDS) for the systematic tracking of Alzheimer’s disease (AD) progression in a population with Down syndrome (DS). A retrospective dual-center cohort study was conducted with 83 participants with DS (46.65 ± 5.08 years) who formed the primary diagnosis (PD) group: cognitive stability (n = 48), mild cognitive impairment (n = 24), and Alzheimer’s disease (n = 11). The proposed scale for adults with DS (GDS-DS) comprises six stages, from cognitive and/or behavioral stability to advanced AD. Two neuropsychologists placed the participants of the PD group in each stage of the GDS-DS according to cognitive, behavioral and daily living skills data. Inter-rater reliability in staging with the GDS-DS was excellent (ICC = 0.86; CI: 0.80–0.93), and the agreement with the diagnosis categories of the PD group ranged from substantial to excellent with κ values of 0.82 (95% CI: 0.73–0.92) and 0.85 (95% CI: 0.72, 0.99). Performance with regard to the CAMCOG-DS total score and orientation subtest of the Barcelona test for intellectual disability showed a slight progressive decline across all the GDS-DS stages. The GDS-DS scale is a sensitive tool for staging the progression of AD in the DS population, with special relevance in daily clinical practice.This research was funded by the Spanish Government, grant number PI12/02019, PSI-2014-53524-P. The APC was funded by S.E.-C,’s SESMDI research start-up funds

    High Incidence of Copy Number Variants in Adults with Intellectual Disability and Co-morbid Psychiatric Disorders

    Get PDF
    Altres ajuts: Financial support was received from "Fundació Parc Taulí Institut d'Investigació i Innovació Parc Taulí I3PT" (Grant Nos. CIR2009/33, CIR2010/034) and "Fundació Barnola-Vallribera 2011".A genetic analysis of unexplained mild-moderate intellectual disability and co-morbid psychiatric or behavioural disorders is not systematically conducted in adults. A cohort of 100 adult patients affected by both phenotypes were analysed in order to identify the presence of copy number variants (CNVs) responsible for their condition identifying a yield of 12.8% of pathogenic CNVs (19% when including clinically recognizable microdeletion syndromes). Moreover, there is a detailed clinical description of an additional 11% of the patients harbouring possible pathogenic CNVs-including a 7q31 deletion (IMMP2L) in two unrelated patients and duplications in 3q29, 9p24.2p24.1 and 15q14q15.1-providing new evidence of its contribution to the phenotype. This study adds further proof of including chromosomal microarray analysis (CMA) as a mandatory test to improve the diagnosis in the adult patients in psychiatric services

    A common cognitive, psychiatric, and dysmorphic phenotype in carriers of NRXN1 deletion

    Get PDF
    Altres ajuts: Fundació Parc Taulí - Institut Universitari UAB CIR2009/33 i CIR2010/034Deletions in the 2p16.3 region that includes the neurexin (NRXN1) gene are associated with intellectual disability and various psychiatric disorders, in particular, autism and schizophrenia. We present three unrelated patients, two adults and one child, in whom we identified an intragenic 2p16.3 deletion within the NRXN1 gene using an oligonucleotide comparative genomic hybridization array. The three patients presented dual diagnosis that consisted of mild intellectual disability and autism and bipolar disorder. Also, they all shared a dysmorphic phenotype characterized by a long face, deep set eyes, and prominent premaxilla. Genetic analysis of family members showed two inherited deletions. A comprehensive neuropsychological examination of the 2p16.3 deletion carriers revealed the same phenotype, characterized by anxiety disorder, borderline intelligence, and dysexecutive syndrome. The cognitive pattern of dysexecutive syndrome with poor working memory and reduced attention switching, mental flexibility, and verbal fluency was the same than those of the adult probands. We suggest that in addition to intellectual disability and psychiatric disease, NRXN1 deletion is a risk factor for a characteristic cognitive and dysmorphic profile. The new cognitive phenotype found in the 2p16.3 deletion carriers suggests that 2p16.3 deletions might have a wide variable expressivity instead of incomplete penetrance

    BRCA1 loss activates cathepsin L–mediated degradation of 53BP1 in breast cancer cells

    Get PDF
    Loss of 53BP1 rescues BRCA1 deficiency and is associated with BRCA1-deficient and triple-negative breast cancers (TNBC) and with resistance to genotoxic drugs. The mechanisms responsible for decreased 53BP1 transcript and protein levels in tumors remain unknown. Here, we demonstrate that BRCA1 loss activates cathepsin L (CTSL)–mediated degradation of 53BP1. Activation of this pathway rescued homologous recombination repair and allowed BRCA1-deficient cells to bypass growth arrest. Importantly, depletion or inhibition of CTSL with vitamin D or specific inhibitors stabilized 53BP1 and increased genomic instability in response to radiation and poly(adenosine diphosphate–ribose) polymerase inhibitors, compromising proliferation. Analysis of human breast tumors identified nuclear CTSL as a positive biomarker for TNBC, which correlated inversely with 53BP1. Importantly, nuclear levels of CTSL, vitamin D receptor, and 53BP1 emerged as a novel triple biomarker signature for stratification of patients with BRCA1-mutated tumors and TNBC, with potential predictive value for drug response. We identify here a novel pathway with prospective relevance for diagnosis and customization of breast cancer therapy

    El Palacio de los Marqueses de la Floresta, de Tárrega

    No full text
    Forma part del projecte: Biblioteca Digital d'Història de l'Art Hispànic (UAB)Localització de l'original: Col·lecció particularObra escrita el 1958 per Ramon Novell sobre el Palau dels Marquesos de la Floresta a Tàrrega. L'estudi tracta de diferents aspectes relacionats amb l'edifici, des de grans personatges, la Capella, la reconstrucció del Palau, etc.Obra escrita en 1958 por Ramon Novell sobre el Palacio de los Marqueses de la Floresta en Tarrega. El estudio trata de diferentes aspectos relacionados con el edificio, desde grandes personajes, la Capilla, la reconstrucción del Palacio, etc.Work written in 1958 by Ramon Novell about the Palau dels Marquesos de la Floresta i Tarrega. The stugy deals with different aspects related to the building: great personalities, the Chapel, the reconstruction of the palace, etc

    Pipeline for deep learning data curation

    No full text

    Measuring monetary policy shocks in the European Monetary Union

    No full text
    The paper tries to estimate whether a unique and centralized European monetary policy would have had similar or different effects across countries in the European Union. By estimating a vector auto-regression (VAR model), it is revealed that there are two different groups of countries with considerable differences in the response to changes in the monetary policy. Germany and the North-Central European countries would be less sensitive to these changes, whereas the Mediterranean countries (and Belgium) would be noticeably more sensitive to the mentioned variations.
    corecore